Headline
The latest stories from AHA Today.
David Zaas, M.D., chief clinical officer for MUSC Health in South Carolina and CEO of its Charleston Division, talks with Nancy Foster, AHA vice president for quality and patient safety, about strategies and tools to address burnout as health care professionals continue to care for COVID-19…
A new report from the National Academies of Sciences, Engineering, and Medicine examines the advantages, limitations and status of certain COVID-19 diagnostic tests, including reverse transcription polymerase chain reaction tests, point-of-care tests, and next generation sequencing tests.
The Department of Veterans Affairs released an interim final rule clarifying that VA nurses and other health care professionals can deliver health care services in a state other than their state of licensure, registration, certification or other requirement.
ECRI tested 34 disposable isolation gown models made by foreign or non-traditional suppliers and found that about half did not meet the minimum U.S. standard for liquid barrier protection, the organization said in a report released.
The Food and Drug Administration Nov. 10 issued an emergency use authorization for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab.
Hundreds of hospital and health system leaders urged senators and representatives to support key priorities, including additional COVID-19 relief, during Congress’ lame-duck session.
The Medicare Part A deductible for inpatient hospital services will increase by $76 in calendar year 2021, to $1,484, the Centers for Medicare & Medicaid Services announced.
The Centers for Medicare & Medicaid Services finalized a 2018 proposed rule implementing policy changes recommended by state Medicaid directors and others to streamline managed care regulations for the Medicaid and Children’s Health Insurance Program.
AHA will provide live coverage and analysis of the Nov. 10 U.S. Supreme Court oral arguments in the latest challenge of the Affordable Care Act.
The Food and Drug Administration issued an emergency use authorization for the first serology test to identify individuals with neutralizing antibodies from recent or prior infection with the virus that causes COVID-19.